Clinical trial
Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
NCT00091325 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00091325 |
|---|---|
| Title | Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants |
| Official title | Phase I Drug Interaction Clinical Study of Polyphenon E |
| Lead sponsor | University of Arizona, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement |
| Interventions | defined green tea catechin extract |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2005 |
| First posted | Sep 9, 2004 |
| Last update posted | Jan 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: